Evidence map›Paper›PMID 17494738›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2007

APEx 2-hybrid, a quantitative protein-protein interaction assay for antibody discovery and engineering.

Ki Jun Jeong, Min Jeong Seo, Brent L Iverson, George Georgiou

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Engineering antibody fragments to fold in the absence of disulfide bonds.Protein science : a publication of the Protein Society · 2009
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 3 countries.

Ki Jun JeongDepartment of Chemical Engineering, Institute for Cellular and Molecular Biology, University of Texas, Austin, TX 78712, USA.
Min Jeong Seo
Brent L Iverson
George Georgiou
Institut de Biologie Moléculaire et Cellulaire · FRThe University of Texas at Austin · US

Funding

Anthrax Antidote in AnimalsU01AI056431 · NIAID · UNIVERSITY OF TEXAS AUSTIN · PI IVERSON, BRENT L · 2003 to 2005
$1.1M
NIAID NIH HHS U01 AI056431NIAID NIH HHS U01 AI56431
6 · The paper itself

Abstract

We have developed a bacterial system for the discovery of interacting proteins that, unlike other two-hybrid technologies, allows for the selection of protein pairs on the basis of affinity or expression. This technology relies on the anchored periplasmic expression (APEx) of one protein (bait) on the periplasmic side of the inner membrane of Escherichia coli and its interacting partner (prey) as a soluble, epitope-tagged, periplasmic protein. Upon removal of the outer membrane by spheroplasting, periplasmic proteins, including any unbound epitope-tagged prey, are released into the extracellular fluid. However, if the epitope-tagged prey can bind to the membrane-anchored bait, it remains associated with the cell and can be detected quantitatively by using fluorescent anti-epitope tag antibodies. Cells expressing prey:bait pairs exhibiting different affinities can be readily distinguished by flow cytometry. The utility of this technology, called APEx two-hybrid, was demonstrated in two demanding antibody engineering applications: First, single-chain variable fragment (scFvs) with increased affinity to the protective antigen of Bacillus anthracis were isolated from cells coexpressing libraries of scFv random mutants, together with endogenously expressed antigen. Second, APEx two-hybrid coupled with multicolor FACS analysis to account for protein expression was used for the selection of mutant Fab antibody fragments exhibiting improved expression in the bacterial periplasm.

Indexed as

Protein EngineeringTwo-Hybrid System TechniquesAntibodiesAntibody AffinityAntigensFlow CytometryHumansImmunoglobulin Variable RegionPeriplasmProtein BindingAntibodiesAntigensImmunoglobulin Variable Region

Identifiers

PMID17494738
PMCPMC1895937
OpenAlexW2129213961

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.